U.S. Markets close in 5 hrs, 26 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,256.34 | 29.40 | 0.29% |
| NASDAQ | 2,158.87 | 4.81 | 0.22% |
| S&P 500 | 1,095.65 | 2.57 | 0.24% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| EPS (TTM): | -0.17 | Current P/E Ratio: | -3.52941 |
|---|---|---|---|
| Last Quarter's Earnings: | -0.03 | Current Quarter Estimate: | -0.034 |
| Last Fiscal Year Earnings: | -0.21 | Next Fiscal Year Estimate: | -0.13 |
| Analyst Consensus: | — | Dividend Rate: | 0.00 |
| Last Dividend: | 0.00 |
First Call Consensus Recommendation
-2147483648 Analysts Reporting
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 11/12/2009 * | 18:00 | Q3 2009 RegeneRx Biopharmaceuticals, Inc. Earnings Release |  |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 09/10/2009 | RegeneRx Biopharmaceuticals, Inc. at Rodman & Renshaw Annual Global Investment Conference | — | — |
| 08/14/2009 | Q2 2009 RegeneRx Biopharmaceuticals, Inc. Earnings Release | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts